《2016+APASL+丙型肝炎病毒感染共识和治疗程序》.pdfVIP

Hepatol Int DOI 10.1007/s12072-012-9342-y GUIDELINES APASL consensus statements and management algorithms for hepatitis C virus infection Masao Omata • Tatsuo Kanda • Ming-Lung Yu • Osamu Yokosuka • Seng-Gee Lim • Wasim Jafri • Ryosuke Tateishi • Saeed S. Hamid • Wan-Long Chuang • Anuchit Chutaputti • Lai Wei • Jose Sollano • Shiv Kumar Sarin • Jia-Horng Kao • Geoffrey W. McCaughan Received: 14 September 2011 / Accepted: 21 January 2012 Asian Pacific Association for the Study of the Liver 2012 Abstract The Asian Pacific Association for the Study of studies. Finalized recommendations are presented in this the Liver (APASL) convened an international working review. party on the ‘‘APASL Consensus Statements and Man- agement Algorithms for Hepatitis C Virus Infection’’ in Keywords APASL DAAs Guideline HCV December, 2010, in order to revise ‘‘Asian Pacific Asso- Treatment ciation for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection (J Gastroenterol Hepatol 22:615–633, Laboratory testing for HCV infection and fibrosis 2007)’’. The working party consisted of expert hepatolo- gists from the Asian-Pacific region gathered at Makuhari, Serologic assays Chiba, Japan on 19 December 2010. New data were pre- sented, discussed and debated to draft a revision. Partici- Exposure to hepatitis C virus (HCV) is usually determined by pants of the consensus meeting assessed the quality of cited testing for specific antibodies (anti-HCV antibodies) by using an approved enzyme or chemiluminescent immunoassay M. Omata () A. C